31P A global examination of clinical trials for patients with salivary gland cancers: An in-depth review of international registries and current challenges
Year: 2025
Type: article
Abstract: Clinical trials (CTs) are crucial for improving the level of scientific evidence and clinical outcomes, but can be challenging in rare subtypes of cancers. Salivary Gland Cancers (SGC) are rare and highly heterogenic tumours, lacking approved systemic therapies and good responses. Their rarity and usual absence of centralized management significantly reduces the chances to develop CTs. We performed a descriptive analysis of SGC CTs to map the landscape of CT activity for patients with SGC.
Source: ESMO Open
Institutions: Royal Marsden Hospital, IRCCS Humanitas Research Hospital, University College London, The Christie Hospital, The Christie NHS Foundation Trust, The University of Texas MD Anderson Cancer Center, Institute of Cancer Research, Dana-Farber Cancer Institute, Vall d'Hebron Hospital Universitari
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W4408737145